Menu icon
A vertical stack of three evenly spaced horizontal lines.
Business Insider logo
Markets Insider logo
Search markets
Search icon
A magnifying glass. It indicates, "Click to perform a search".
My Watchlist
Markets
Stocks
Indices
Commodities
Cryptocurrencies
Currencies
ETFs
News
Calendar icon
An icon in the shape of a calendar.
Economic
Earnings
Search markets
Search icon
A magnifying glass. It indicates, "Click to perform a search".
Search icon
A magnifying glass. It indicates, "Click to perform a search".
Markets Insider logo
Close icon
Two crossed lines that form an 'X'. It indicates a way to close an interaction, or dismiss a notification.
Markets
Bonds
Funds
Pre-Market
Market Movers
Dow Jones Live
Your Portfolio
Stocks
Stocks Finder
Market Movers
Index Constituents
Earnings Calendar
Dividends
Indices
Market Movers
Index Constituents
Dow Jones Live
S&P 500 Live
Nasdaq Live
World Map
Commodities
News
Commodities Live
Gold
Oil
Copper
Cryptocurrencies
Bitcoin
Ethereum
Cryptocurrencies Live
Currencies
News
Currencies Live
Currency Converter
EUR/USD
GBP/USD
US Dollar Index
ETFs
News
ETF Finder
ETF Issuers
News
My Watchlist
My Watchlist
Facebook Icon
The letter F.
Twitter icon
A stylized bird with an open mouth, tweeting.
LinkedIn icon
YouTube icon
A play button in the shape of a television screen.
Instagram icon
A stylized camera.
Business Insider logo
© 2024
Insider Inc. and
finanzen.net
GmbH (Imprint). All rights reserved.
Registration on or use of this site constitutes acceptance of our
Terms of Service
and
Privacy Policy.
Disclaimer
Accessibility
Commerce Policy
Advertising Policies
Stock quotes by
finanzen.net
Home
News
News for Colgate-Palmolive Co.
InvestorPlace
5d
7 Defensive Stocks to Buy as Investors Seek Shelter
InvestorPlace
6d
7 Divine Dividend Stocks to Buy for Another Market Crash
InvestorPlace
7d
7 Recession-Proof Dividend Stocks to Buy Before the Next Crash
InvestorPlace
17d
7 Safe Stocks to Pick Up Amid Incoming Uncertainty
TipRanks
19d
Bernstein Keeps Their Hold Rating on Colgate-Palmolive (CL)
Seeking Alpha
20d
Procter & Gamble falls after organic sales miss expectations
TipRanks
20d
DBS downgrades Colgate-Palmolive (CL) to a Hold
TipRanks
21d
Strong Buy Rating for Colgate-Palmolive Amid Robust Growth and Strategic Execution
TipRanks
21d
Bank of America Securities Sticks to Their Buy Rating for Colgate-Palmolive (CL)
TipRanks
21d
Colgate-Palmolive (CL) Receives a Buy from J.P. Morgan
TipRanks
21d
Evercore ISI Sticks to Its Buy Rating for Colgate-Palmolive (CL)
TipRanks
21d
Colgate-Palmolive: A Strong Buy on Robust Performance and Positive Growth Outlook
TipRanks
21d
Wells Fargo Keeps Their Hold Rating on Colgate-Palmolive (CL)
InvestorPlace
24d
CL Stock Earnings: Colgate-Palmolive Beats EPS, Beats Revenue for Q2 2024
Markets Insider Automation
24d
Colgate-Palmolive hosts conference call for investors
Seeking Alpha
24d
4 stocks to watch on Friday: BMY, MMM and more
RTTNews
24d
Colgate-Palmolive Boosts FY24 Adj. EPS, Organic Sales Growth Outlook - Update
RTTNews
24d
Colgate-Palmolive Co. Q2 Profit Increases, Beats Estimates
TipRanks
24d
Colgate-Palmolive’s Strong Q2 Performance and Upward Revision in Outlook Justify Buy Recommendation
Seeking Alpha
24d
Earnings summary: Colgate-Palmolive beats Q2 earnings; raises FY24 organic sales and EPS growth outlook
Seeking Alpha
24d
Colgate-Palmolive gains after earnings topper and hiked profit guidance
Seeking Alpha
24d
Colgate-Palmolive beats top-line and bottom-line estimates; updates FY24 outlook
TipRanks
24d
Barclays Remains a Hold on Colgate-Palmolive (CL)
Seeking Alpha
25d
Colgate-Palmolive Q2 2024 Earnings Preview
Markets Insider Automation
25d
Colgate-Palmolive is about to announce its earnings — here's what to expect
Seeking Alpha
25d
Notable earnings before Friday's open
Benzinga
26d
Mondelez Q2 Earnings in the Cards: Factors to Watch
TipRanks
26d
Colgate-Palmolive (CL) Receives a Hold from RBC Capital
TipRanks
27d
Stifel Nicolaus Remains a Buy on Colgate-Palmolive (CL)
TipRanks
28d
Colgate-Palmolive: A Strong Buy on Innovation, Market Dominance, and Growth Potential
TipRanks
28d
J.P. Morgan Reaffirms Their Buy Rating on Colgate-Palmolive (CL)
Seeking Alpha
29d
Earnings week ahead: TSLA, GOOG, IBM, AAL, GM, F, VZ, T, and more
Seeking Alpha
30d
Financials dominate in Q2 as Wall Street slides amidst concerns on tech - Earnings Scorecard
InvestorPlace
30d
3 Defensive Stocks to Shield Your Portfolio in July
Seeking Alpha
31d
Catalyst watch: Earnings deluge, Farnborough Airshow, Paris Olympics, and Trump talks crypto
TipRanks
31d
Barclays Remains a Hold on Colgate-Palmolive (CL)
TipRanks
32d
Colgate-Palmolive (CL) Gets a Buy from Evercore ISI
Benzinga
34d
Post Holdings Rallies 21% YTD: How to Play the Stock?
TipRanks
35d
Strategies for Crafting Effective Analyst Recommendation Reports
Seeking Alpha
38d
Dividend Roundup: Procter & Gamble, Costco, CVS Health, Colgate-Palmolive, and more
Benzinga
40d
Expert Outlook: Colgate-Palmolive Through The Eyes Of 12 Analysts
TipRanks
40d
Bank of America Securities Sticks to Their Buy Rating for Colgate-Palmolive (CL)
TipRanks
40d
Wells Fargo Sticks to Its Hold Rating for Colgate-Palmolive (CL)
Benzinga
41d
J. M. Smucker Down 15% in 6 Months: How to Play Ahead?
TipRanks
41d
RBC Capital Remains a Hold on Colgate-Palmolive (CL)
InvestorPlace
47d
7 Blue-Chip Cash Cows to Milk for Steady Income
TipRanks
52d
Wall Street Analysts Are Bullish on Top Consumer Goods Picks
Benzinga
56d
Analyst Ratings For Colgate-Palmolive
TipRanks
63d
Buy Rating for Colgate-Palmolive: Poised for Sustained Outperformance and Justified Premium Valuation
Seeking Alpha
67d
Colgate-Palmolive declares $0.50 dividend
Page
Page
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
Page
Colgate-Palmolive Peer Group News
09/21/20
Healthcare stocks plunge amid broad market rout as Ruth Bader Ginsburg's death creates uncertainty around Obamacare
08/19/20
Momenta Pharmaceuticals spikes 69% after agreeing to $6.5 billion Johnson & Johnson takeover
10/09/19
J&J slides after jury orders it to pay $8 billion in male breast-growth case (JNJ)
10/02/19
Johnson & Johnson climbs after settling two opioid epidemic lawsuits, allowing it to avoid an upcoming federal trial (JNJ)
08/27/19
J&J was ordered to pay $572 million for helping fuel the opioid epidemic. The company's market cap increased $15 billion in response. (JNJ)
07/30/19
Procter & Gamble climbs after reporting its strongest sales growth in more than a decade (PG)
04/16/19
Johnson & Johnson's net earnings dropped 14% in the first-quarter (JNJ)
02/21/19
Johnson & Johnson was subpoenaed by the DOJ and the SEC over baby powder safety (JNJ)
Find News
News
GO